CIK 0001535955 · Non-accelerated filer<br>Smaller reporting company
Lipocine Inc.
Sign in to watch- Ticker
- LPCN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990370688
- Phone
- 801 994 7383
- Business address
- 675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, United States, 84108
- Former names
- MARATHON BAR CORP
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and President bought 25,000 shares at $1.09 ($27,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 6,700 shares at an average $1.35 ($9,054)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 3,750 shares (option exercise)
- 4 Option exercise Director acquired 5,250 shares (option exercise)
- 4 Option exercise Director acquired 5,625 shares (option exercise)
- 4 Option exercise Director acquired 7,500 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 15,000 shares at $1.35 ($20,250)
- 4 Open-market sale EVP and CFO sold 8,437 shares at $1.35 ($11,390)
- 4 Open-market sale Chief Executive Officer sold 43,500 shares at $1.57 ($68,134)
- 4 Open-market sale Chief Financial Officer sold 17,250 shares at $1.57 ($27,024)
- 4 Derivatives Options or other derivatives
Page 4 of 9 · 175 filings